Work

Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000210426

Authors: Cassandra Snipes, Alexander Kuka, Mariya Petrova, Timothy Peters-Strickland, Laura Taraboanta, Olya Besedina, Stewart J. Tepper, Shaheen Lakhan

Institutions: Click Therapeutics, Inc. (United States), New England Institute for Neurology and Headache

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409227114

FWCI: 1.907

Cites:

Cited by: 3

Related to: 10